SCHEMBL25369429

SCHEMBL25369429

Cn1c(=O)oc2ccc(-c3ccc(CC(C#N)NC(=O)[C@@H]4CN(C(=O)OC(C)(C)C)CCCO4)c(F)c3)cc21

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CTSC P53634 20/20 0.58
▸ CTSK P43235 1/20 0.51
▸ KCNH2 Q12809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24981976 1.00 CTSC (0.58) CTSCCTSKKCNH2
SCHEMBL28989283 1.00 CTSC (0.58) CTSCCTSKKCNH2
SCHEMBL29455307 0.95 CTSC (0.53) CTSCCTSKKCNH2
SCHEMBL28989371 0.93 CTSC (0.49) CTSCCTSKKCNH2
SCHEMBL28989376 0.93 CTSC (0.49) CTSCCTSKKCNH2
SCHEMBL28989374 0.93 CTSC (0.49) CTSCCTSKKCNH2
SCHEMBL30738864 0.93 CTSC (0.52) CTSCCTSKKCNH2
SCHEMBL25146472 0.92 CTSC (0.55) CTSCCTSKKCNH2
SCHEMBL28989310 0.92 CTSC (0.55) CTSCCTSKKCNH2
SCHEMBL28989313 0.92 CTSC (0.55) CTSCCTSKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118742547-A Preparation method of nitrogen-containing heterocyclic compound 西藏海思科制药有限公司 2024-10-01 — — CN disclosed
CN-118660873-A Salts and crystalline forms of dipeptidyl peptidase inhibitor compounds 西藏海思科制药有限公司 2024-09-17 — — CN disclosed
WO-2023160542-A1 SALT AND CRYSTAL FORM OF DIPEPTIDYL PEPTIDASE INHIBITOR COMPOUND 四川海思科制药有限公司 2023-08-31 — — WO disclosed
WO-2023160541-A1 PREPARATION METHOD OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND 四川海思科制药有限公司 2023-08-31 — — WO disclosed
CN-115996923-A Nitrile derivative as dipeptidyl peptidase 1 inhibitor and application thereof 四川海思科制药有限公司 2023-04-21 — — CN disclosed
Send feedback